Community Optometrist–Led Monitoring of Quiescent Neovascular Age-Related Macular Degeneration: The FENETRE - Report - MDSpire

Community Optometrist–Led Monitoring of Quiescent Neovascular Age-Related Macular Degeneration: The FENETRE

  • By

  • Anitta Sharma

  • Aljazy Jaber

  • Bishwanath Pal

  • John G. Lawrenson

  • Robert A. Harper

  • Adnan Tufail

  • Annastazia E. Learoyd

  • Emily Robinson

  • Abdel Douiri

  • Rachel Burman

  • Ashleigh Kernohan

  • Sofia Vougioukalou

  • Simon Read

  • Judit Csontos

  • Aled Jones

  • Sajjad Mahmood

  • Martin McKibbin

  • Janet L. Peacock

  • Richard Gale

  • Praveen J. Patel

  • Pearse A. Keane

  • Robin Hamilton

  • Luke Vale

  • Catey Bunce

  • Konstantinos Balaskas

  • June 15, 2026

  • 0 min

Share

Clinical Report: Community-Based Optometrist Monitoring for Stable Neovascular AMD

Overview

{'add': "Define 'noninferior' in layman's terms."}

Background

{'add': 'Include specific statistics on AMD case projections.'}

Data Highlights

{'expand': 'Provide details on trial methodology and participant demographics.'}

Key Findings

{'correct': "Change 'QnAMD' to 'nAMD' where applicable."}

Clinical Implications

{'add': 'List specific patient populations for community monitoring.'}

Conclusion

{'add': 'Emphasize the importance of findings for healthcare efficiency.'}

Related Resources & Content

  1. JAMA Network Open, 2023 -- Caution Against Overinterpretation of Results in the FENETRE Trial
  2. Retinal Physician, 2025 -- Clinical Trial Update June 2025
  3. NICE, 2023 -- Recommendations | Age-related macular degeneration | Guidance
  4. Retinal Physician — Clinical Trials Update
  5. Retinal Physician — Clinical Trial Update
  6. Age-Related Macular Degeneration Preferred Practice Pattern® - Ophthalmology
  7. Quality-Assured Integrated Clinical Care Model for Community Monitoring of Neovascular Age-Related Macular Degeneration
  8. Recommendations | Age-related macular degeneration | Guidance | NICE
  9. The Royal College of Ophthalmologists National Ophthalmology Database age-related macular degeneration (AMD) audit: report 1, associations with socio-economic deprivation in neovascular AMD
  10. Aflibercept 8⠋mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel
  11. Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial - ScienceDirect
  12. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2 - PubMed
  13. Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular Degeneration - PMC
  14. Roche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD)
  15. Evaluation of training, patient and practitioner perspectives on community-based monitoring of patients with stable age-related macular degeneration compared to hospital-based care: The FENETRE study report no. 1 - PMC
  16. Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study
  17. Pivotal Trial Validating Usability and Visualization Performance of Home OCT in Neovascular Age-Related Macular Degeneration: Report 1 - PMC

Original Source(s)

Related Content